Zynga reports disappointing earnings
Facebook has changed our lives, and few companies have benefited from this development more than Zynga, the company that brought you FarmVille. There are tons of people on Facebook playing annoying (to most of us) but addictive (to some of us) games that clog up our timelines, unless you block them of course.
The problem for Zynga is that it’s getting harder and also much more expensive to develop the new addictive games, and that led to disappointing earnings, which then led to its stock getting crushed. That then led to the further decline of Facebook’s stock as well, making this a very tough week for social media companies.
As gadgets keep evolving and as new social media platforms evolve, companies like Zynga can rocket to success, but then it’s hard to keep up that pace. Consumers are incredibly fickle these days. Just ask phone makers like Blackberry and Nokia. You’re on top of the world, and then Steve Jobs puts out the iPhone and soon your high-flying company is staring into the abyss.
Zynga is trying to avoid that fate. One of their latest games might help them, as Zynga Poker was launched for Facebook and has taken off as the #1 poker app on iOS. The key here, however, is that Zynga is looking past casual gaming. As the feds try to sort out online poker regulations, Zynga is one of many companies that want to take on the most popular poker sites. They want a piece of what could be a very large pie when we finally get uniform poker regulations. They’ll have to battle the big casino companies of course, but this could be a much-needed boost for a bruised social media star.
Posted in: Gaming
Tags: facebook, farmville, games, poker, poker games, zynga, Zynga poker
Utilization Of Mycobacterium Tuberculosis Antigen-based Skin Tests For The Diagnosis Of TB Infection: Updated
WHO Guidelines
The use of Mycobacterium tuberculosis antigen-based skin tests is a key
component in the diagnosis of tuberculosis infections, as outlined in the updated WHO
consolidated guidelines. These tests provide a reliable method for detecting exposure to M.
tuberculosis.
**Use Of Mycobacerium Tuberculosis Antigen-based Skin Tests For
The Diagnosis Of TB Infection**
The diagnosis of tuberculosis (TB) infection is critical for controlling the
spread of this preventable disease. Recent advancements
in diagnostic methods, particularly the use of Mycobacterium tuberculosis antigen-based skin tests, have revolutionized how
we identify and manage TB infections. The World Health Organization (WHO) has released new consolidated guidelines that emphasize the importance of these tests in combating
global TB trends.
**Background**
Tuberculosis remains a leading cause of mortality worldwide, particularly in low-resource settings.
Traditional diagnostic methods, such as sputum smear microscopy, have limitations in accuracy and accessibility.
The introduction of antigen-based skin tests offers a more reliable and faster way
to diagnose TB infection. These tests detect specific proteins
produced by Mycobacterium tuberculosis, allowing for quicker results without the
need for complex laboratory equipment.
**Recommendation**
The WHO guidelines recommend the use of these antigen-based skin tests as an alternative diagnostic
method, particularly in resource-limited settings
where traditional methods may be unavailable or insufficient.
They are recommended for both initial diagnosis and surveillance of TB infections.
**2.1. Justification**
The justification for this recommendation stems
from the improved accuracy and simplicity of antigen-based tests.
Studies have shown high sensitivity and specificity, making them effective in identifying infected
individuals. Additionally, these tests require minimal technical expertise and resources, making them suitable for use in areas with limited healthcare infrastructure.
**2.2. Subpopulations**
The guidelines specify that these tests are particularly beneficial for high-risk populations,
such as close contacts of TB patients, children under 15 years of age, and individuals with HIV/AIDS.
These groups often face higher risks of infection and may benefit more from accurate and timely diagnosis.
**Test Descriptions**
Antigen-based skin tests, such as the interferon-γ release assay (IGRA)
and the tuberculin skin test (TST), are commonly used.
The TST involves injecting a TB antigen into the skin and measuring the immune
response after two days. IGRAs provide similar benefits but may offer better specificity for TB
infection.
**Evidence Base**
The evidence supporting the use of these tests is robust, with numerous studies demonstrating their diagnostic accuracy.
Sensitivity levels as high as 94-100% have been reported, indicating a high likelihood of accurate diagnosis.
*Fig. 1*: Example of a tuberculin skin test (TST) result.
A positive reaction indicates exposure to TB bacteria.
*Fig. 2*: Comparison of TST and IGRAs in detecting active and latent TB infections.
**4.1. Diagnostic Accuracy**
The diagnostic accuracy of antigen-based tests is a key strength.
Sensitivity, or the ability to detect true positives, is consistently high, reducing the risk
of missed diagnoses. Specificity, which ensures that false positives are minimized, has also been demonstrated in clinical trials.
*Fig. 3*: Chart showing sensitivity and specificity rates across different study
populations.
**4.2. Safety**
These tests are generally safe with mild side effects, such as minor
discomfort or swelling at the injection site. They pose no significant risk of severe adverse
events, making them suitable for widespread use in various settings.
*Fig. 4*: Photograph of a healthcare worker administering an IGRAs test.
**4.3. Cost and Cost-Effectiveness Analysis**
The cost-effectiveness of antigen-based tests varies depending on the setting.
In low-resource areas, the upfront costs may be high, but the long-term savings from reduced treatment costs and decreased transmission are significant.
*Fig. 5*: Bar graph illustrating the cost per test in dollars
across different regions.
**4.4. User Perspective**
User perspectives highlight the ease of use and quick results as major
advantages. However, there is some uncertainty about the acceptability
among patients and healthcare providers due to varying levels of awareness about these
tests. Ensuring proper training and communication can address
these concerns.
*Fig. 6*: Diagram showing patient and provider feedback on antigen-based skin tests.
**Implementation Considerations**
Successful implementation requires adequate training for healthcare workers, standardized protocols,
and access to supplies. Integration with existing TB control programs is crucial to ensuring sustained impact.
**Monitoring and Evaluation**
Regular monitoring of test performance, accuracy, and cost-effectiveness is necessary to maintain the effectiveness of these
diagnostic tools. Data collection and analysis can help identify
areas for improvement and ensure continued progress in TB diagnosis.
*Fig. 7*: Table summarizing key performance indicators for antigen-based tests across
different regions.
**Research Priorities**
Future research should focus on improving the accuracy of antigen-based tests, reducing costs, and exploring their use in combination with other diagnostic methods to
enhance diagnostic algorithms.
**Footnotes**
1. The WHO guidelines emphasize that these tests should not replace existing reliable methods
but rather complement them.
2. Further studies are needed to determine long-term outcomes and cost-effectiveness in various settings.
Views: This article reflects the latest advancements in TB diagnosis, offering a concise overview of the evidence
supporting antigen-based skin tests. Other titles in this collection may provide additional insights into
TB prevention and control strategies.
**In this Page**
– **Recent Activity**: Stay updated with the latest developments in global
health research and policy.
Feel free to visit my web-site; negative effect definition, Christ
ena,